Rare diseases
Investigational molecules
Locations
Study Comparing Subcutaneous and Intravenous Ocrelizumab for Patients with Multiple Sclerosis
CzechiaStudy Comparing bb2121 with Standard Treatments for Patients with Relapsed and Refractory Multiple Myeloma
BelgiumStudy of PF-07220060 and PF-07104091 with Endocrine Therapy for Patients with Advanced HR-positive HER2-negative Breast Cancer
BulgariaStudy on Leflunomide and Hydroxychloroquine for Patients with Primary Sjögren's Syndrome
The NetherlandsStudy on the Effects of Somapacitan and Somatropin in Children with Growth Hormone Deficiency
AustriaStudy of Immunotherapy Combinations with GSK4428859, Dostarlimab, and GSK6097608 for Patients with Advanced Non-Small Cell Lung Cancer
BelgiumStudy on the Effectiveness and Safety of Amlitelimab for Patients Aged 12 and Older with Moderate-to-Severe Atopic Dermatitis Using Topical Corticosteroids
BulgariaStudy of Enpatoran in Adults with Systemic Lupus Erythematosus (SLE) and Cutaneous Lupus Erythematosus (CLE)
BulgariaStudy on Atezolizumab with Radiotherapy for Patients with Muscle-Invasive Bladder Cancer
SpainStudy on the Effectiveness and Safety of Alectinib, Entrectinib, and a Drug Combination for Patients with Advanced or Metastatic Non-Small Cell Lung Cancer
BelgiumLong-Term Safety Study of Obefazimod for Patients with Moderate to Severe Ulcerative Colitis
AustriaStudy on Ticagrelor for Patients with Heart Attack After Coronary Stenting
SwedenTell us about your condition – we search every trial in Europe and connect you with the right site.
